HPV Vaccine Slashes Cervical Cancer Death Risk, Study Finds
A landmark study published in the medical journal The Lancet has found that the human papillomavirus (HPV) vaccine has reduced the risk of dying from cervical cancer before the age of 30 in England to nearly zero, providing the strongest evidence yet that the immunisation programme is saving lives. The study revealed that no women…